# The Research of Metabolomics on COPD

> **NCT04042519** · — · COMPLETED · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 200 (actual)

## Conditions studied

- Metabolomics
- Omega 6
- Omega 3
- COPD

## Interventions

- **DIAGNOSTIC_TEST:** Lung function test was performed on the subjects with Jaeger lung function instrument of Germany.
- **DIAGNOSTIC_TEST:** Agilent 1290 Infinity LC system (UHPLC, Santa Clara CA) was used for Targeted metabolite detection.
- **DIAGNOSTIC_TEST:** Routine blood test

## Key facts

- **NCT ID:** NCT04042519
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2018-10-01
- **Final completion:** 2019-07-05
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2019-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04042519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04042519, "The Research of Metabolomics on COPD". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04042519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*